GJeorgjieva janev, Olivera
Preferred name
GJeorgjieva janev, Olivera
Official Name
GJeorgjieva janev, Olivera
7 results
Now showing 1 - 7 of 7
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Case report on a switch from hypothyroidism to hyperthyroidism(The Endocrine Society, 2023-01-18) ;Todorova, Biljana; ; ;Stevcevska, AleksandraHashimoto's thyroiditis and Graves’ disease are the most common autoimmune thyroid conditions and are more common in women than in men. Thyrotropin receptor (TSHR) antibodies that stimulate the thyroid (TSAb) cause Graves’ hyperthyroidism and TSHR antibodies which block thyrotropin action (TBAb) are occasionally responsible for hypothyroidism. Unusual patients switch from TSAb to TBAb (or vice versa) with concomitant thyroid function changes.The most common scenario is the evolution from Graves’ disease (GD) to Hashimoto's thyroiditis (HT), whereas the switch from HT into GD seems to be less common. 53-year-old woman presented with a several month's history of tiredness, cold intolerance and hoarseness in October 2020. She was diagnosed with autoimmune hypothyroidism and achieved euthyroid status following treatment with Tbl. Levothyroxine a 50 mcg S. 1×1. This almost stable status was interestingly interrupted after 9 months (January 2021) when the patient on a regular checkup got laboratory results that showed suppressed TSH levels and a high fT4. The substitution therapy was discontinued immediately. The ultrasound of the thyroid gland showed nonspecific changes: hypoechoic, inhomogeneous gland without any markable pathological formations. The patient was feeling tired, she had palpitations, sweating that is not connected to a physical activity, shaking of the hands and uncontrolled movements of the extremities and neck. Her hair started to fall rapidly in the past few months. She was given Tbl. Metoprolol a 100 mg S.1×1 and Tbl ASA a 100 mg S. 1X1.In October 2021, the new laboratory results showed TSH <0.005 mU/l; fT4 =33.36, aTP-O= 22.77 iU/ml thyroglobulin =46,62, Calcitonin=2.99, Vit. D3=27.3, TSH receptor antibodies= 15.40. Antithyroid therapy was required, and she was given Tbl Thiamazole, Tbl. Propronalol because of the developed clinically and laboratory confirmed hyperthyroidism. There were oscillations in the thyroid status in the first months after the switch to hyperthyroidism, and in December 2021 there was a discontinuation of the Thiamazole treatment for one month because of the unstable TSH level, but afterwards from January 2022 the therapy is administered again and the patient is so far clinically stable under regular control. The patient is feeling good. Conclusion:This rare switch from a state of hypothyroidism to a state of hyperthyroidism is not very common in the clinical endocrinology practice, but should not be missed or misdiagnosed. Suspicion should be raised in the very first moment of tapering the levothyroxine doses in any patient with diagnosed HT during a regular follow up. Our recommendation is doing the TRABs (if available) at the moment of lowering the levothyroxine doses along with the regular laboratory tests of fT4, TSH, ATP-O. If there are any TRABs elevated, the leading way is to think and manage the possible and probable onset of hyperthyroidism - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Emphysematous pyelonephritis and sepsis in a diabetic female patient caused by extended-spectrum beta-lactamase-producing Escherichia coli – case report(Slovenian Medical Association, 2023-07-13); ; ; ; <jats:p>Emphysematous pyelonephritis (EPN) is a rare, severe, spontaneous gas-forming infection of renal parenchyma and its surrounding areas. EPN was detected in diabetic patients. A 49-year-old female with type I diabetes mellitus presented with severe thrombocytopenia, acute kidney injury (AKI) and was in need of haemodialysis treatment. She had impaired liver function tests, with active urine sediment, indicating severe upper urinary tract infection with suspected sepsis. The contrast enhanced CT scan of the abdomen showed multiple areas of air density in renal parenchyma and perirenal regions, suggestive of left-side EPN. The blood and urine cultures reported growth of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli. The final diagnosis of emphysematous pyelonephritis complicated with severe sepsis and AKI was established. The patient was managed conservatively with wide-spectrum antibiotics, fluid resuscitation, consistent blood sugar control, and haemodialysis treatment. Percutaneous drainage techniques (PCD) and nephrectomy were postponed because of the initial clinical response to the antibiotics treatment. However, the patient experienced sudden clinical deterioration and died only a few hours after the established diagnosis. An autopsy was not performed upon the patient’s family’s request. EPN should be highly suspected in poorly controlled diabetic patients with urinary tract infection and should be promptly recognized and aggressively treated. The patients with multiple risk factors had high mortality, even with timely diagnosis and combined (conservative and surgical) treatment.</jats:p> - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Late onset of SLE in males: A misdiagnosed disease(Macedonian Association of Anatomists and Morphologists, 2022); ; Systemic lupus erythematosus (SLE) is an autoimmune disease characterisedby the production of antibodies to components of the cell nucleus in association with a diverse array of clinical manifestations. When the immune system attacks its own tissues, it causes widespread inflammation and tissue damage in the affected organs. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels. The primary pathological findings in patients with SLE are those of inflammation, vasculitis, immune complex deposition, and vasculopathy.Late-onset SLE represents a specific subgroup of SLE and is often initially missed leading to a significant delay in diagnosis. Elderly patients frequently present to hospital with nonspecific symptoms such as fatigue, recurrent fever of an unknown cause, weight loss, serositis (pleural and/or pericardial effusions), and acute kidney injury.We are describing a case of late onset SLE in a male patient that has been previously only syptomaticaly treated for the complications of the disease itself, whilst it took a longer period for physicians to thinkof SLE and make further investigations about it, because of the age and sex of the patient. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ANTISYNTHETASE SYNDROME: A RARE AND CHALLENGING DIAGNOSIS – CASE REPORT AND LITERATURE REVIEW(Central Medical Library - Bulgaria, 2022-10); ; ; Antisynthetase syndrome (ASS) is rare idiopathic inflammatory myopathy (IIM) characterized principally by myositis, generally symmetrical arthritis and interstitial lung disease (ILD) in association with serum autoantibodies to aminoacyl-transfer RNA synthetases. More variable features include arthralgia, Raynaud phenomenon, heliotrophic rash, distal esophageal dysmotility and mechanic's hands. In this case report we describe a 46-years old woman who initially presented with arthritis and subtle myositis which delayed the recognition of ASS and contributed for considering the condition as seronegative rheumatoid arthritis for several years. During the next few years, the patient was progressively worsening, with a disability to stand up from a sitting position, gradual onset of exertional dyspnea, difficult-to-control dry cough and thick, hyperkeratotic skin of both hands (mechanic’s hands). This constellation of symptoms was highly suspicious for ASS and additional serological and radiological examinations were done which confirmed the diagnosis. The need for further detailed investigation when an interstitial lung disease overlaps with a known rheumatoid condition is obligatory, as shown in this case. A multidisciplinary evaluation is highly recommended to evaluate the clinical, serological and radiological findings in each patient suspected for ASS in order to establish early diagnosis and timely management. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus, a diagnostic and a management challenge(Bulgarian Rheumatology Society, 2023-08-31) ;Krstevski, Mirko; Thrombotic thrombocytopenic purpura (TTP) is a rare, potentially fatal blood disorder that can be challenging for clinicians to identify in the setting of autoimmune diseases such as systemic lupus erythematosus (SLE). SLE can present with thrombotic microangiopathy (TMA) and differentiation between the two diseases can be quite difficult. In this case report we present a 62-year-old female with a history of SLE who was hospitalized with thrombocytopenia, dysarthria, dizziness, paresthesia and altered mental status. The laboratory results revealed direct Coombs negative hemolytic anemia, severe thrombocytopenia, significant elevation of lactate dehydrogenase, leukocytosis and presence of few schistocytes in the peripheral film. In addition, we also present evidence for circulating anti-ADAMTS13 antibody/ADAMTS13 antigen. Based on clinical, hematological, and biochemical findings, we concluded that it was a case of TTP-like microangiopathy associated with SLE and indicated treatment with methylprednisolone pulses and plasmapheresis. Later on, she developed psychosis and made plasmapheresis difficult to perform. We continued corticosteroids (dose 1mg/kg), RhoGAM, Chloroquine and Azathioprine, obtaining a satisfactory response after one week of treatment. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Excellent Response to Alectinib in ALK Positive NSLC Adenocarcinoma, Case Report and Literature Review(Macedonian Association of Anatomists and Morphologists, 2023); ;Pachoska Stojchevska, VesnaNon small cell lung carcinoma (NSCLC) is a type of lung carcinoma that slowly grows within the lung tissue. Hence, it is often diagnosed late when the disease has already progressed and passed to other body organs and/or lymph nodes. In most cases, this makes NSCL inoperable at the exact moment of diagnosing, which leads to the necessity of using chemotherapy that has the purpose of narrowing the extended masses in the lungs and/or any near/further metastases. Alectinib is a tyrosine k inase inhibitor (TKI) that is currently being used as a first line target therapy in treating the inoperable ALK rearranged NSCLC, but still the effectiveness of the treatment is not definitely known and examined. Herein, we present the case of a 51 year old male patient admitted to our hospital with hemoptysis for 2 weeks. Contrast enhanced computerized tomography (CT) of the chest showed an approximately 28x23 mm soft tissue mass infiltrating the lumen of the right bronchus and causing obstruction. On the same side at the base, a hypodense nodule of 19 mm with some surrounding pneumonic reaction and irregular contours was detected. Several significant lymph nodes were detected in the hilar and mediastinal regions. Bronchial biopsy of the mass showed pulmonary adenocarcinoma and the immunohistochemical testing results confirmed ALK rearrangements. TKI Alectinib was given at a dosage of 600mg twice per day for 13 cycles, achieving a complete response of the disease with complete regression of the mass in the right bronchus, complete regression of the right nodule and hilar and mediastinal lymph nodes were not detected following the treatment. The patient continued to receive Alectinib and did not report any specific discomfort at his 13th month follow up. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, BULL’S EYE: IS THIS PHENOMENON GIVEN ENOUGH ATTENTION(Macedonian Association of Anatomists and Morphologists, 2024); ;Mediha Lushi Selimi ;Pecanova, Blagica ;Pachoska, VesnaChloroquine maculopathy is not such a rare complication of long-term use of chloroquine preparations in the treatment of rheumatological diseases. Its early detection is of exceptional importance for timely discontinuation of the drug in order to preventirreversible vision damage.The aim of this Article is to present a case of a 62-year-old patient with bull's eye maculopathy as a result of long-term use of chloroquine due to systemic lupus erythematosus. The patient appeared with blurring and distortion of the pericentral vision. She was ophthalmologically evaluated with fundoscopic examination, autofluorescence, perimetry, optical coherent tomography which together with her medical history established a diagnosis of chloroquine maculopathy. Chloroquine therapy was discontinued and the patient is regularly monitored by a Rheumatologist and an Ophthalmologist, with no disease progression so far.
